Oncology

Search


 

 


Oncology

Cancer is the second leading cause of death in the United States. Since 1990, approximately 16 million new cancer cases have been diagnosed.*
*American Cancer Society. Cancer Facts and Figures. 2002.

LabCorp offers a full range of tests that assist physicians in the prediction, diagnosis, treatment, and monitoring of such diseases as bladder, breast, cervical, melanoma, colorectal and prostate cancer. Its scientific expertise in oncology testing means LabCorp is critical to the process of determining the optimal course of treatment for cancer patients.


Human papillomavirus (HPV) Cervical cancer is the second most common cancer in women worldwide. Infection with oncogenic human papillomavirus (HPV) types is the most significant risk factor in the development of cervical cancer. More than 99% of cervical cancers have detectable HPV DNA sequences. LabCorp offers HPV reflex testing from a liquid-based Pap specimen. Click here for more information.

Top of Page

 

Home | About LabCorp | Centers of Excellence | Services | Connectivity Solutions | Site Map

For questions or comments about this site, please contact the LabCorp Webmaster.
Privacy Statement
©2007 Laboratory Corporation of America® Holdings
All Rights Reserved